Cost-effectiveness profile, organizational implications and patient preferences on the use of exogenous TSH therapy (Thyrogen®) vs. THW in thyroid residue ablation in Italy

Cost-effectiveness profile, organizational implications and patient preferences on the use of exogenous TSH therapy (Thyrogen®) vs. THW in thyroid residue ablation in Italy

BACKGROUND: Radioiodine ablation is an adjuvant procedure used to treat patients with differentiated thyroid cancer. For ablation to be successful, patients must have elevated levels of thyroid stimulating hormone (TSH). This can be achieved by withholding thyroid hormone therapy (endogenous stimula...

Full description

Bibliographic Details
Main Authors: Gianluca De Danieli, Fabio Monari, Renzo Lazzarini, Filippo Cipriani
Format: Article
Language:English
Published: SEEd Medical Publishers 2016-10-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
radioiodine ablation
recombinant human thyroid stimulating hormone
thyroidectomy
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1264

Similar Items

Similar Items